| BASEC ID | Project title | Type of project | Type of clinical trial | Study phase (clinical trials only) | multi- / monocentric | Category | Principal investigator | Sponsor | Investigational sites | Lead EC | Local EC(s) | Approval date | Minors | Study Ended | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-00532 | DUND-101947 PruvinNextGeneration | personal data/biological material | monocentric | Dr. Philipp Gut | Nestec Ltd |
Nestlé Research, Lausanne |
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) | 21.06.2019 | Study has ended | ||||||
| 2019-00531 | Begleitevaluation vom Home Treatment und der Übergangsbehandlung der Universitären Psychiatrischen Kliniken (UPK) Basel | non clinical, involving persons | monocentric | A | Dr. phil. Julian Möller | Universitäre Psychiatrische Kliniken |
Universitäre Psychiatrische Kliniken, Basel |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 14.05.2019 | ||||||
| 2019-00529 | Feasibility and effects of taking cold showers: A randomized controlled study | clinical trial | other clinical trials | monocentric | A | Prof. Dr. Jens Gaab | University of Basel |
University of Basel, Basel |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 24.09.2019 | |||||
| 2019-00528 | A phase 3, multicenter, randomized, open-label, active-controlled trial of DS-8201a, an anti-HER2-antibody drug conjugate (ADC), versus treatment of physician’s choice for HER2-low, unresectable and/o More ... | clinical trial | drugs | phase 3 | multicentric | C | Dr. med. Andreas Müller | Daiichi-Sankyo |
Kantonsspital Winterthur, Winterthur Tumor Zentrum Aarau, Aarau Universitätsspital Basel, Basel Kantonsspital, St. Gallen CHUV, Lausanne Universitätsspital Zürich, Zürich Kantonsspital Graubünden, Chu More ... |
Kantonale Ethikkommission Zürich | Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) | 04.12.2019 | Study has ended | ||
| 2019-00526 | Validation Sonic Bone’s Ultrasound System for Bone Age Assessment (BAUS) | clinical trial | medical devices | monocentric | A | Dr. Michael Romann | Bundesamt für Sport |
Bundesamt für Sport, Magglingen |
Kantonale Ethikkommission Bern | 03.09.2019 | yes | ||||
| 2019-00524 | Evaluation of Fluid Filled Expression Core Technology Study - I | clinical trial | other clinical trials | monocentric | A | Beatrix Mascher | Medela AG |
Medela AG, Baar |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 24.04.2019 | Study has ended | ||||
| 2019-00523 | Differentiation of Malignant and Benign Pulmonary Nodules Using Classic Prediction Models, Human Observer’s analysis and Deep Learning Developed Analytics. A Comparative Study | personal data/biological material | monocentric | PD Alban LOVIS | Service de Pneumologie CHUV |
CHUV, Lausanne |
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) | 04.06.2019 | |||||||
| 2019-00522 | Long-term outcome of endovascular coiling of intracranial aneurysms: a retrospective cohort study (Masterthese) | personal data/biological material | monocentric | Dr. med. Daniel Walter Zumofen | Universitätsspital Basel |
Universitätsspital Basel, Basel |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 11.07.2019 | |||||||
| 2019-00520 | ACETA - Therapie von Acetabulumfrakturen des älteren Patienten | personal data/biological material | monocentric | PD Dr Henrik Eckardt | University Hospital Basel |
University Hospital Basel, Basel |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 27.03.2019 | |||||||
| 2019-00519 | M14-675: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcera More ... | clinical trial | drugs | phase 3 | multicentric | C | Prof. Dr. med. Dr. phil. Gerhard Rogler | AbbVie AG |
UniversitätsSpital Zuerich, Zuerich Inselspital, Bern Universitätsspital Basel, Basel Kantonsspital St. Gallen, St. Gallen |
Kantonale Ethikkommission Zürich | Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern | 13.06.2019 | Study has ended | ||
| 2019-00518 | Determining human non-beta-cell targets to foster islet cell-type interconversion | deceased persons | monocentric | Prof. Pedro Herrera | University of Geneva |
University of Geneva, Geneva |
Commission Cantonale d'éthique de la recherche Genève (CCER) | 17.09.2019 | |||||||
| 2019-00516 | Auswirkungen einer homöopathischen Behandlung auf die Blasenfunktion bei Personen mit einer neurogenen Blasenfunktionsstörung nach einer Querschnittlähmung – eine retrospektive Kohorten Studie | personal data/biological material | monocentric | Prof. Dr. med. Jürgen Pannek | Neuro-Urologie |
Schweizer Paraplegiker-Zentrum, Nottwil |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 15.04.2019 | Study has ended | ||||||
| 2019-00515 | Does Fugl Meyer Assessment for upper extremities follow a fixed hierarchical proximo-distal pattern post stroke? | personal data/biological material | monocentric | MSc. | cereneo |
cereneo, Vitznau |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 10.07.2019 | |||||||
| 2019-00514 | Randomized controlled trial on the efficacy of a virtual reality exposure-based eye contact training to reduce fear of public speaking | clinical trial | other clinical trials | monocentric | A | Dominique de Quervain | University of Basel |
University of Basel, Basel |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 29.04.2019 | Study has ended | ||||
| 2019-00513 | D9108C00002: A Phase 2 Open-label, Multicenter, Randomized, Multidrug Platform Study of Neoadjuvant Durvalumab Alone or in Combination with Novel Agents in Subjects with Resectable, Early-stage (I [> More ... | clinical trial | drugs | phase 2 | monocentric | C | PD Dr. med. Alessandra Curioni | MedImmune, LLC |
UniversitätsSpital Zürich, Zürich |
Kantonale Ethikkommission Zürich | 23.08.2019 | Study has ended | |||
| 2019-00511 | High-throughput sequencing for the identification of viruses in adult allogeneic hematopoietic stem cell transplant recipients requiring second line immunosuppressive treatments for severe acute and c More ... | personal data/biological material | monocentric | Professor Laurent Kaiser | University of Geneva Hospitals |
University of Geneva Hospitals, Geneva |
Commission Cantonale d'éthique de la recherche Genève (CCER) | 30.04.2019 | |||||||
| 2019-00510 | Trajectory of microbiota maturation in healthy Bern infants – a network approach | non clinical, involving persons | monocentric | A | Prof. Dr. rer. nat. Stephanie Ganal-Vonarburg | Department for BioMedical Research (DBMR) |
Department of Biomedical Research (DBMR), UVCM, Inselspital, Bern |
Kantonale Ethikkommission Bern | 01.05.2019 | yes | |||||
| 2019-00509 |
A multicenter Phase 1a/1b study of safety, tolerability, whole-body radiodistribution, and radiation dosimetry of Debio 1124 in patients with unresectable locally advanced or metastatic solid tumor More ... |
clinical trial | drugs | phase 1 | multicentric | C | Dr. Christof Rottenburger | Debiopharm International S.A. |
Universitätsspital Basel, Klinik für Radiologie und Nuklearmedizin, CH-4031 Basel Unité de Recherche DFDL, Geneve Universitätsspital Zürich, Klinik für Medizinische Onkologie und Hämatologie, Zürich |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | Kantonale Ethikkommission Zürich, Commission Cantonale d'éthique de la recherche Genève (CCER) | 08.07.2019 | Study has ended | ||
| 2019-00508 | Vergleich von Asservierungstupfern für genitale Abstriche hinsichtlich DNA-Ausbeute und Handling | non clinical, involving persons | monocentric | A | Dr. rer. medic. Iris Schulz | IRM Basel |
IRM Basel, Basel |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 07.05.2019 | Study has ended | |||||
| 2019-00506 | Usability, safety and efficacy of Aspivix, an atraumatic innovative uterine cervical traction device: a pilot phase followed by a comparative study | clinical trial | medical devices | multicentric | C2 | Prof Patrice Mathevet | Aspivix SA |
CHUV, Lausanne Hôpitaux Universitaires Genève, Geneva |
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) | Commission Cantonale d'éthique de la recherche Genève (CCER) | 18.02.2020 | Study has ended | |||